Rogletimide

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C12H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 14P4QR28QF, chemically known as 2,6-piperidinedione, 3-ethyl-3-(4-pyridinyl)- but generally known as rogletimide, which bears US NIH Compound Identifier 56487. European Medicines Agency schedules Rogletimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10360MIG. The term ROGLETIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). ROGLETIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rogletimide under HS 29333999 and SITC 51574. As of Q4 2014, ROGLETIMIDE remains the US FDA Preferred Term for this commodity. Rogletimide bears US NLM identifiers UMLS ID C0164550 and NCI Concept Code C1427. SMILES: CCC1(CCC(=O)NC1=O)C2=CC=NC=C2.